Strong Support

For adults with type 2 diabetes and kidney problems, taking a weekly semaglutide shot (1.0 mg) can lower their chances of serious kidney or heart issues by about a quarter over 3.4 years — about 1 in every 20 people who take it will avoid a major problem.

82
Pro
0
Against

Evidence from Studies

Supporting (1)

82

Community contributions welcome

The study tested the exact same drug, dose, and patient group as described in the claim, and found it reduced serious kidney and heart problems by 24%, just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.